Log In
Print
BCIQ
Print
Print this Print this
 

dapagliflozin (Forxiga)

Also known as: formerly BMS-512148

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionSodium-glucose cotransporter 2 (SGLT2) inhibitor
Molecular Target Sodium-glucose cotransporter 2 (SGLT2)
Mechanism of ActionSodium-glucose cotransporter 2 (SGLT2) inhibitor
Latest Stage of DevelopmentApproved
IndicationDiabetes
Partner

AstraZeneca plc
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today